Cargando…

Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients

Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury that follows exposure to intravascular contrast media. Although a series of preventive measures have been developed, CIN remains a major challenge encountered in elderly patients by interventional cardiologists. No data...

Descripción completa

Detalles Bibliográficos
Autores principales: XU, RONG-HE, MA, GUI-ZHOU, CAI, ZHI-XIONG, CHEN, PING, ZHU, ZHI-DAN, WANG, WEN-LIANG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797303/
https://www.ncbi.nlm.nih.gov/pubmed/24137279
http://dx.doi.org/10.3892/etm.2013.1258
_version_ 1782287598821048320
author XU, RONG-HE
MA, GUI-ZHOU
CAI, ZHI-XIONG
CHEN, PING
ZHU, ZHI-DAN
WANG, WEN-LIANG
author_facet XU, RONG-HE
MA, GUI-ZHOU
CAI, ZHI-XIONG
CHEN, PING
ZHU, ZHI-DAN
WANG, WEN-LIANG
author_sort XU, RONG-HE
collection PubMed
description Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury that follows exposure to intravascular contrast media. Although a series of preventive measures have been developed, CIN remains a major challenge encountered in elderly patients by interventional cardiologists. No data are currently available concerning the potential effects of the combined use of hydration and alprostadil in the prevention of CIN following percutaneous coronary intervention (PCI) in elderly patients. Therefore, the aim of the present study was to investigate the ability of a combination of hydration and alprostadil to prevent CIN following PCI in elderly patients. From June 1, 2010 to January 31, 2012, 85 elderly patients undergoing PCI were included in the present study. The included patients were randomly allocated into three groups: the control (22 cases), hydration (28 cases) and hydration + alprostadil (35 cases) group. Serum creatinine (SCr) levels were measured prior to PCI and then daily for 3 days following PCI. Creatinine clearance (Ccr) was also calculated. Following investigation of the incidence of CIN, a significant decline in Ccr was observed in the control group but not in the hydration + alprostadil group after PCI. The reduction in the level of Ccr from baseline in the hydration + alprostadil group was the smallest among the three groups. Moreover, the highest incidence of CIN was in the control group (6 cases, 27.27%), followed by the hydration group (3 cases, 10.71%) and the hydration + alprostadil group (1 case, 2.86%). Therefore, the combined use of hydration and alprostadil significantly reduces the incidence of CIN in elderly patients undergoing PCI. Hydration and alprostadil are suggested to act synergistically to protect renal function. In conclusion, the combined use of hydration and alprostadil is more effective in the prevention of CIN in elderly patients undergoing PCI compared with hydration alone.
format Online
Article
Text
id pubmed-3797303
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-37973032013-10-17 Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients XU, RONG-HE MA, GUI-ZHOU CAI, ZHI-XIONG CHEN, PING ZHU, ZHI-DAN WANG, WEN-LIANG Exp Ther Med Articles Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury that follows exposure to intravascular contrast media. Although a series of preventive measures have been developed, CIN remains a major challenge encountered in elderly patients by interventional cardiologists. No data are currently available concerning the potential effects of the combined use of hydration and alprostadil in the prevention of CIN following percutaneous coronary intervention (PCI) in elderly patients. Therefore, the aim of the present study was to investigate the ability of a combination of hydration and alprostadil to prevent CIN following PCI in elderly patients. From June 1, 2010 to January 31, 2012, 85 elderly patients undergoing PCI were included in the present study. The included patients were randomly allocated into three groups: the control (22 cases), hydration (28 cases) and hydration + alprostadil (35 cases) group. Serum creatinine (SCr) levels were measured prior to PCI and then daily for 3 days following PCI. Creatinine clearance (Ccr) was also calculated. Following investigation of the incidence of CIN, a significant decline in Ccr was observed in the control group but not in the hydration + alprostadil group after PCI. The reduction in the level of Ccr from baseline in the hydration + alprostadil group was the smallest among the three groups. Moreover, the highest incidence of CIN was in the control group (6 cases, 27.27%), followed by the hydration group (3 cases, 10.71%) and the hydration + alprostadil group (1 case, 2.86%). Therefore, the combined use of hydration and alprostadil significantly reduces the incidence of CIN in elderly patients undergoing PCI. Hydration and alprostadil are suggested to act synergistically to protect renal function. In conclusion, the combined use of hydration and alprostadil is more effective in the prevention of CIN in elderly patients undergoing PCI compared with hydration alone. D.A. Spandidos 2013-10 2013-08-08 /pmc/articles/PMC3797303/ /pubmed/24137279 http://dx.doi.org/10.3892/etm.2013.1258 Text en Copyright © 2013, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
XU, RONG-HE
MA, GUI-ZHOU
CAI, ZHI-XIONG
CHEN, PING
ZHU, ZHI-DAN
WANG, WEN-LIANG
Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
title Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
title_full Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
title_fullStr Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
title_full_unstemmed Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
title_short Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
title_sort combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797303/
https://www.ncbi.nlm.nih.gov/pubmed/24137279
http://dx.doi.org/10.3892/etm.2013.1258
work_keys_str_mv AT xuronghe combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients
AT maguizhou combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients
AT caizhixiong combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients
AT chenping combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients
AT zhuzhidan combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients
AT wangwenliang combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients